fibroblasts were
maintained in mouse embryonic fibroblast (MEF) containing Dulbecco’s
modified Eagle’s medium (DMEM) glutamax (Life Technologies),
supplemented with 10% fetal bovine serum (Sigma-Aldrich) and 1% penicillin/streptomycin
(Life Technologies). Viral transduction was performed as described
previously.76 (link) Briefly, a lentiviral vector
expressing OCT4, KLF4, SOX2, c-MYC, and a mixture containing MEF medium
and 4 mg/mL hexadimethrine bromide (Sigma) was used. Cells were incubated
for 24 h in this mixture, followed by MEF medium for 5 days. Hereafter,
cells were transferred to irradiated MEFs in human embryonic stem
cell (huES) medium containing DMEM-F12 (Life Technologies), knockout
serum replacement (Life Technologies), penicillin/streptomycin,
Technologies), β-mercaptoethanol (Merck Millipore), and 20 ng/mL
recombinant human fibroblast growth factor-basic (bFGF; Life Technologies).
Potential iPSC colonies were selected on the basis of their embryonic
stem cell-like morphology. Feeder-free iPSCs were cultured on Geltrex-coated
dishes (Life Technologies) in mTeSR1 medium (Stem Cell Technologies)
and passaged enzymatically with Accutase (Innovative Life Technologies).
All cell lines were tested for mycoplasma contamination every other
week.